Rockwell Medical Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在藥品行業排名96/158位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價3.75。中期看,股價處於下降通道。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Rockwell Medical Inc評分
相關信息
行業排名
96 / 158
全市場排名
247 / 4582
所屬行業
藥品
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
2
分析師
買入
評級
3.750
目標均價
+312.27%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Rockwell Medical Inc亮點
亮點風險
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
公司代碼RMTI
公司Rockwell Medical Inc
CEOStrobeck (Mark)
網址https://www.rockwellmed.com/
常見問題
Rockwell Medical Inc(RMTI)的當前股價是多少?
Rockwell Medical Inc(RMTI)的當前股價是 0.849。
Rockwell Medical Inc 的股票代碼是什麼?
Rockwell Medical Inc的股票代碼是RMTI。
Rockwell Medical Inc股票的52週最高點是多少?
Rockwell Medical Inc股票的52週最高點是2.410。
Rockwell Medical Inc股票的52週最低點是多少?
Rockwell Medical Inc股票的52週最低點是0.780。
Rockwell Medical Inc的市值是多少?
Rockwell Medical Inc的市值是33.46M。
Rockwell Medical Inc的淨利潤是多少?
Rockwell Medical Inc的淨利潤為-480.00K。
現在Rockwell Medical Inc(RMTI)的股票是買入、持有還是賣出?
根據分析師評級,Rockwell Medical Inc(RMTI)的總體評級為買入,目標價格為3.750。
Rockwell Medical Inc(RMTI)股票的每股收益(EPS TTM)是多少
Rockwell Medical Inc(RMTI)股票的每股收益(EPS TTM)是-0.164。